Diana Resetca

Exploiting and engineering hemoproteins for abiological carbene and nitrene transfer reactions

Targeting oxidative stress in disease: promise and limitations of antioxidant therapy

Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution

The JAK/STAT signaling pathway: from bench to clinic

Nucleic acid-based approaches to STAT inhibition

Oxidative Stress in Cancer

Oncogenic pathways and the electron transport chain: a dangeROS liaison

Structure of a designed tetrahedral protein assembly variant engineered to have improved soluble expression

Overcoming an optimization plateau in the directed evolution of highly efficient nerve agent bioscavengers

Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligently

Changes in Signal Transducer and Activator of Transcription 3 (STAT3) Dynamics Induced by Complexation with Pharmacological Inhibitors of Src Homology 2 (SH2) Domain Dimerization

Inhibitors of Stat5 protein signalling

Characterizing rapid, activity‐linked conformational transitions in proteins via sub‐second hydrogen deuterium exchange mass spectrometry

MYC Deregulation in Primary Human Cancers

Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent